<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1016/j.diabres.2019.02.017</dc:identifier><dc:language>eng</dc:language><dc:creator>Mavrogianni, C.</dc:creator><dc:creator>Lambrinou, C.P.</dc:creator><dc:creator>Androutsos, O.</dc:creator><dc:creator>Lindström, J.</dc:creator><dc:creator>Kivelä, J.</dc:creator><dc:creator>Cardon, G.</dc:creator><dc:creator>Huys, N.</dc:creator><dc:creator>Tsochev, K.</dc:creator><dc:creator>Iotova, V.</dc:creator><dc:creator>Chakarova, N.</dc:creator><dc:creator>Rurik, I.</dc:creator><dc:creator>Moreno, L.A.</dc:creator><dc:creator>Liatis, S.</dc:creator><dc:creator>Makrilakis, K.</dc:creator><dc:creator>Manios, Y.</dc:creator><dc:title>Evaluation of the Finnish Diabetes Risk Score as a screening tool for undiagnosed type 2 diabetes and dysglycaemia among early middle-aged adults in a large-scale European cohort. The Feel4Diabetes-study</dc:title><dc:identifier>ART-2019-111194</dc:identifier><dc:description>Aim: To assess the diagnostic accuracy of the FINDRISC for undiagnosed type 2 diabetes mellitus (T2DM) and dysglycaemia (i.e. the presence of prediabetes or T2DM) among early middle-aged adults from vulnerable groups in a large-scale European cohort. Methods: Participants were recruited from low-socioeconomic areas in high-income countries (HICs) (Belgium-Finland) and in HICs under austerity measures (Greece-Spain) and from the overall population in low/middle-income countries (LMICs) (Bulgaria-Hungary). Study population comprised of 2116 parents of primary-school children from families identified at increased risk of T2DM, based on parental self-reported FINDRISC. Sensitivity (Se), specificity (Sp), area under the receiver operating characteristic curves (AUC-ROC) and the optimal cut-offs of FINDRISC that indicate an increased probability for undiagnosed T2DM or dysglycaemia were calculated. Results: The AUC-ROC for undiagnosed T2DM was 0.824 with optimal cut-off =14 (Se = 68%, Sp = 81.7%) for the total sample, 0.839 with optimal cut-off =15 (Se = 83.3%, Sp = 86.9%) for HICs, 0.794 with optimal cut-off =12 (Se = 83.3%, Sp = 61.1%) for HICs under austerity measures and 0.882 with optimal cut-off =14 (Se = 71.4%, Sp = 87.8%) for LMICs. The AUC-ROC for dysglycaemia was 0.663 with optimal cut-off =12 (Se = 58.3%, Sp = 65.7%) for the total sample, 0.656 with optimal cut-off =12 (Se = 54.5%, Sp = 64.8%) for HICs, 0.631 with optimal cut-off =12 (Se = 59.7%, Sp = 62.0%) for HICs under austerity measures and 0.735 with optimal cut-off =11 (Se = 72.7%, Sp = 70.2%) for LMICs. Conclusion: FINDRISC can be applied for screening primarily undiagnosed T2DM but also dysglycaemia among vulnerable groups across Europe, considering the use of different cut-offs for each subpopulation.</dc:description><dc:date>2019</dc:date><dc:source>http://zaguan.unizar.es/record/87829</dc:source><dc:doi>10.1016/j.diabres.2019.02.017</dc:doi><dc:identifier>http://zaguan.unizar.es/record/87829</dc:identifier><dc:identifier>oai:zaguan.unizar.es:87829</dc:identifier><dc:relation>info:eu-repo/grantAgreement/EC/H2020/643708/EU/Developing and implementing a community-based intervention to create a more supportive social and physical environment for lifestyle changes to prevent diabetes in vulnerable families across Europe/Feel4Diabetes</dc:relation><dc:relation>This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No H2020 643708-Feel4Diabetes</dc:relation><dc:identifier.citation>DIABETES RESEARCH AND CLINICAL PRACTICE 150 (2019), 99-110</dc:identifier.citation><dc:rights>All rights reserved</dc:rights><dc:rights>http://www.europeana.eu/rights/rr-f/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>